A key decision point in the generic development process during "Phase 4: Testing and refinement" is concept approval.

Name: A key decision point in the generic development process during "Phase 4: Testing and refinement" is concept approval.
Brand: Quizplus
Rating: 4.9 (40 reviews)

Question

Quizplus · Accepted Answer

The key decision point in Phase 4 is actually the submission of the New Drug Application (NDA) to the regulatory authority for review and approval. Concept approval typically occurs earlier in the development process, during Phase 1 or Phase 2.

A Key Decision Point in the Generic Development Process During